Drug Repurposing Patent Applications July–September 2022
- 1 December 2022
- journal article
- research article
- Published by Mary Ann Liebert Inc in ASSAY and Drug Development Technologies
- Vol. 20 (8), 359-366
- https://doi.org/10.1089/adt.2022.097
Abstract
ASSAY and Drug Development TechnologiesThis publication has 52 references indexed in Scilit:
- Overactive Bladder and the β3-Adrenoceptor Agonists: Current Strategy and Future ProspectsDrugs, 2015
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)The Journal of Molecular Diagnostics, 2015
- Comparative Mechanistic Studies of Brilacidin, Daptomycin, and the Antimicrobial Peptide LL16Antimicrobial Agents and Chemotherapy, 2014
- Naproxen and Cromolyn as New Glycogen Synthase Kinase 3β Inhibitors for Amelioration of Diabetes and Obesity: An Investigation by Docking Simulation and Subsequent In Vitro/In Vivo Biochemical EvaluationJournal of Biochemical and Molecular Toxicology, 2013
- Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy)Neurotherapeutics, 2013
- Reinstatement of episodic-like memory in rats by neurokinin-1 receptor antagonismNeurobiology of Learning and Memory, 2007
- RhoA Is Activated During Respiratory Syncytial Virus InfectionVirology, 2001
- Antiviral Activity of Lovastatin against Respiratory Syncytial Virus In Vivo and In VitroAntimicrobial Agents and Chemotherapy, 2001
- Substance P and substance P receptor histochemistry in human neurodegenerative diseasesRegulatory Peptides, 1993
- CG‐4, A new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type‐2 astrocytesJournal of Neuroscience Research, 1992